Gallagher Kathleen P.
Insider CIK 2048409 · RNA Chief Program Officer · RNA See Remarks, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RNA Atrium Therapeutics, Inc. | F Tax w/h | 2026-09-18 | 2026-09-22 | 11,632 | $8.95 | $104.1K | 119,729 | SEC↗ |
| RNA Atrium Therapeutics, Inc. | F Tax w/h | 2026-09-18 | 2026-09-22 | 11,632 | $8.95 | $104.1K | 119,729 | SEC↗ |
| RNA Atrium Therapeutics, Inc. | A Award deriv | 2026-04-20 | 2026-04-22 | 205,000 | — | $0 | 205,000 | SEC↗ |
| RNA Atrium Therapeutics, Inc. | A Award | 2026-04-20 | 2026-04-22 | 102,500 | — | $0 | 131,361 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 27,584 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 16,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 13,520 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 42,480 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 50,000 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 13,352 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 9,244 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 13,829 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer deriv | 2026-02-27 | 2026-02-27 | 22,321 | — | $0 | 0 | SEC↗ |
| RNAM Avidity Biosciences, Inc. | D To issuer | 2026-02-27 | 2026-02-27 | 80,303 | — | $0 | 0 | SEC↗ |
| RNA Avidity Biosciences, Inc. | F Tax w/h | 2025-12-17 | 2025-12-19 | 33,336 | $71.87 | $2.40M | 88,868 | SEC↗ |
| RNA Avidity Biosciences, Inc. | F Tax w/h | 2025-12-17 | 2025-12-19 | 8,030 | $71.87 | $577.1K | 80,838 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2025-12-17 | 2025-12-19 | 72,000 | — | $0 | 122,204 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-09-02 | 2025-09-02 | 188 | $47.42 | $8.9K | 50,204 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-06-17 | 2025-06-18 | 911 | $30.24 | $27.5K | 50,392 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2025-06-02 | 2025-06-04 | 5,875 | — | $0 | 22,596 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2025-06-02 | 2025-06-04 | 5,875 | $16.65 | $97.8K | 56,429 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-06-02 | 2025-06-04 | 5,875 | $32.48 | $190.8K | 50,554 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2025-05-01 | 2025-05-02 | 5,875 | — | $0 | 28,471 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2025-05-01 | 2025-05-02 | 5,875 | $16.65 | $97.8K | 56,429 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-05-01 | 2025-05-02 | 5,875 | $32.40 | $190.3K | 50,554 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2025-04-01 | 2025-04-03 | 5,546 | — | $0 | 13,829 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2025-04-01 | 2025-04-03 | 329 | — | $0 | 34,346 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2025-04-01 | 2025-04-03 | 329 | $16.65 | $5.5K | 50,883 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-04-01 | 2025-04-03 | 329 | $27.83 | $9.2K | 50,554 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-04-01 | 2025-04-03 | 5,546 | $27.83 | $154.3K | 50,554 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2025-04-01 | 2025-04-03 | 5,546 | $14.70 | $81.5K | 56,100 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2025-03-03 | 2025-03-04 | 5,875 | — | $0 | 19,375 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2025-03-03 | 2025-03-04 | 5,875 | $14.70 | $86.4K | 56,429 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-03-03 | 2025-03-04 | 5,875 | $29.41 | $172.8K | 50,554 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise deriv | 2025-02-03 | 2025-02-05 | 5,875 | — | $0 | 34,675 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-02-03 | 2025-02-05 | 5,875 | $32.16 | $188.9K | 50,554 | SEC↗ |
| RNA Avidity Biosciences, Inc. | M Exercise | 2025-02-03 | 2025-02-05 | 5,875 | $16.65 | $97.8K | 56,429 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-01-22 | 2025-01-23 | 5,629 | $30.16 | $169.8K | 50,554 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-01-21 | 2025-01-23 | 670 | $28.60 | $19.2K | 58,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-01-21 | 2025-01-23 | 1,817 | $28.59 | $51.9K | 56,183 | SEC↗ |
| RNA Avidity Biosciences, Inc. | S Sale | 2025-01-21 | 2025-01-23 | 1,295 | $28.59 | $37.0K | 58,670 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award deriv | 2025-01-06 | 2025-01-08 | 50,000 | — | $0 | 50,000 | SEC↗ |
| RNA Avidity Biosciences, Inc. | A Award | 2025-01-06 | 2025-01-08 | 25,000 | — | $0 | 59,965 | SEC↗ |